Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 914-100-5 | CAS number: -
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
No study with potassic extracts are available for this endpoint. Nevertheless, data on individual salts of potassic extracts or on substance of the sulfate category exist and have been used in a read-across approach to evaluate the genotoxic potential of potassic extracts. Then, in in vitro Ames test performed according to OECD test guideline 471 with potassium sulfate, calcium sulfate and sodium sulfate showed no mutagenicity with or without metabolic activation in 4 strains of Salmonella typhimurium (TA98, TA100, TA1535 and TA1537) and/or in E. coli bacteria (WP2 uvr A).
In an in vitro study where chromosome aberrations were tested with potassium sulfate in CHO cells according to OECD test guideline 473 also no effects were found. In addition, in vitro TK assay in L5178Y mouse lymphoma cells with calcium sulfate and magnesium sulfate performed according to OECD 476 showed no genotoxicity. In one in vivo study, performed according to OECD test guideline 474, calcium sulfate was administered to mice.Calcium sulfate, up to the test concentration of 5000 mg/kg bw showed negative effect in the micronucleus test. All together, these available data on substance in the sulfate category support the conclusion that no deleterious effects on genetic toxicity are expected with potassic extracts. Then it can be concluded that potassic extracts are highly unlikely to be mutagenic.Short description of key information:
- Sodium sulfate : negative with and without metabolic activation, in vitro (similar to OECD guideline 471)
- Potassium sulfate: negative with and without metabolic activation, in vitro (according to OECD guideline 471 and 473)
- Calcium sulfate: negative with and without metabolic activation, in vitro (according to OECD guideline 471 and 476)
- Calcium sulfate : negative, in vivo (according to OECD Guideline 474)
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
The available data indicate that no classification is required with regard to mutagenicity for potassic extracts according to Directive 67/548/EC and the CLP regulation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
